ClinicalTrials.gg
Status unknownNCT04047888Updated Aug 7, 2019

Assessment of Risk Factors for Childhood Obesity and Nutrition Education Intervention on Infant Growth and Development

An observational study in Childhood Obesity, sponsored by The University of The West Indies. Status unknown at 1 site in Jamaica. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-07.

Sponsored by The University of The West Indies · Observational

The sponsor has not verified this record recently (last verified Feb 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
152
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The period from conception to 2 years of age ('first 1000 days') has been recognized as a critical period for long-lasting programming effects on later obesity and associated NCD and a window of opportunity to implement intervention for reducing and treating childhood obesity. However, there is a dearth of prospective intervention studies that address this nutritional problem in Jamaica and there are no reports of sustainable intervention.

Jamaica is a middle income country in which overweight and obesity in children are also increasing at an alarming rate. The investigators in Jamaica are seeking to provide a more comprehensive knowledge on the link between early life nutrition and later childhood health and to assess the impact of an intervention of infant feeding counselling/education in mothers on growth and body composition in their offspring.

Read the detailed description

At least 41 million children younger than 5 years are overweight or obese most of whom reside in low-income and middle-income countries (LMIC). Obese children tend to remain obese in adulthood predisposing to the huge personal health and economic burden of the non-communicable diseases (NCD).

Several early life factors identified to contribute to development of obesity and adverse metabolic profile; pre-pregnancy underweight and overweight, high weight gain in early pregnancy in addition to inappropriate infant feeding pattern and rapid weight gain in early life have major role.

The aims of the study are:1) to assess intrauterine and postnatal risk factors for childhood obesity in children followed from the second trimester in mother's pregnancy to age 1 year and 2) to assess the impact of a nutrition-based educational intervention on infant feeding, growth and body composition in the first year of life.

This study design is a cluster randomized clinical trial with key outputs being : 1) The use of deuterium dilution method to provide new data on body composition of mothers from during pregnancy and during infancy in addition to obtain accurate measurement of breastmilk intake 2) new data on the relationship between maternal body composition and/or infant body composition and non-communicable disease risk factors; 3) new data on the impact of a nutrition-based educational on infant's growth and body composition.

02

Conditions studied

  • Childhood Obesity

Browse trials for

03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's planned enrollment of 152 is below the median of 180 across 235 observational studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

The University of The West Indies is the lead sponsor of 64 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The target populations from which participants will be selected will consist of pregnant women attending antenatal visits at Public Health Centers in Kingston and St. Andrew (KSA). Mothers will be recruited prior to 30-32 weeks gestation and study measurements will be made in the middle of the third trimesters

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women (18-40 years)
  • Women 30 -32 weeks gestation
  • First or second pregnancy
  • Healthy term infants ( > 37 completed weeks)
  • Infants with birthweight >2.5kg)

Exclusion criteria

Exclusion Criteria:

  • Pre-gestational diabetes
  • Pre-gestational hypertension
  • Sickle cell disease
  • infection,
  • Psychiatric disorder
  • Gestational diabetes
  • Infants with congenital abnormalities
  • Infants with chromosomal disorders
  • Infants admitted in neonatal period > 48 hours
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
152 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Intervention Group

    Mothers and children in this group will have measurements, questionnaire administration. The children will have routine child care at their health center and mothers will have a 60 minute nutrition-based and non-nutrition based educational message

    Other: Nutrition-based education on infant feeding and practices as well as Non nutrition-based educational message

  • Control Group

    Mothers and babies will have measurements and questionnaire administration and children will receive routine child care at their health centers. These mothers will receive a non-nutrition based educational message only.

    Other: Non nutrition-based educational message

Interventions

  • OtherNutrition-based education on infant feeding and practices as well as Non nutrition-based educational message

    60 minute educational message at each visit

  • OtherNon nutrition-based educational message

    No nutrition-based education on infant feeding and practices

06

What researchers measure

Primary outcomes

  1. Feeding Questionnaire - first assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Time frame: 2 weeks old

  2. Feeding Questionnaire - second assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Time frame: 4 weeks old

  3. Feeding Questionnaire - third assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Time frame: 3 months old

  4. Feeding Questionnaire - fourth assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Time frame: 6 months old

  5. Feeding Questionnaire - fifth assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Time frame: 12 months old

  6. Child's lean mass and fat mass (body composition) determined using skin fold measurements - first assessment

    Child's fat mass and lean mass (body composition) determined using skin fold callipers

    Time frame: 6 months old

  7. Child's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - first assessment

    Child's fat mass and lean mass (body composition) determined using a Bioelectrical Impedance Analyzer

    Time frame: 6 months old

  8. Child's mid-upper arm circumference - first assessment

    Child's mid-upper arm circumference measured using a tape measure

    Time frame: 6 months

  9. Child's lean mass and fat mass (body composition) determined using skin fold measurements - second assessment

    Child's fat mass and lean mass (body composition) determined using skin fold callipers

    Time frame: 12 months old

  10. Child's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - second assessment

    Child's fat mass and lean mass (body composition) determined using a Bioelectrical Impedance Analyzer

    Time frame: 12 months old

  11. Child's mid-upper arm circumference - second assessment

    Child's mid-upper arm circumference measured using a tape measure

    Time frame: 12 months old

  12. Child's fat mass and lean mass (body composition) determined using deuterium dilution method - first assessment

    Measurement of fat mass and lean mass (body composition) using the deuterium dilution method

    Time frame: 6 months old

  13. Child's fat mass and lean mass (body composition) determined using deuterium dilution method - second assessment

    Measurement of fat mass and lean mass (body composition) using the deuterium dilution method

    Time frame: 12 months old

  14. Child's weight in kilograms - first assessment

    Child's weight measured using a digital scale

    Time frame: 4 weeks old

  15. Child's weight in kilograms - second assessment

    Child's weight measured using a digital scale

    Time frame: 3 months old

  16. Child's weight in kilograms - third assessment

    Child's weight measured using a digital scale

    Time frame: 6 months old

  17. Child's weight in kilograms - fourth assessment

    Child's weight measured using a digital scale

    Time frame: 12 months old

  18. Child's length in centimeters - first assessment

    Child's length measured using a stadiometer

    Time frame: 4 weeks old

  19. Child's length in centimeters - second assessment

    Child's length measured using a stadiometer

    Time frame: 3 months old

  20. Child's length in centimeters - third assessment

    Child's length measured using a stadiometer

    Time frame: 6 months old

  21. Child's length in centimeters - fourth assessment

    Child's length measured using a stadiometer

    Time frame: 12 months old

  22. Child's fat mass and lean mass (body composition) determined using Dual-energy X-ray absorptiometry (DEXA)

    A whole body DEXA scan will be done as described by the International Atomic Energy Agency. A scan takes about 7 minutes.

    Time frame: 12 months old

  23. Child's fat mass and lean mass (body composition) determined using Air Displacement Plethysmography - first assessment

    Measurement of child's fat mass and lean mass (body composition) using the Air Displacement Plethysmography

    Time frame: 4 weeks old

  24. Child's fat mass and lean mass (body composition) determined using the Air Displacement Plethysmography - second assessment

    Measurement of child's fat mass and lean mass (body composition) using the Air Displacement Plethysmography

    Time frame: 3 months old

  25. Child's fat mass and lean mass (body composition) determined using the Air Displacement Plethysmography - third assessment

    Measurement of child's fat mass and lean mass (body composition) using the Air Displacement Plethysmography

    Time frame: 6 months old

Secondary outcomes

  1. Screen time / sleep time questionnaire - first assessment

    This will describe total duration of sleep time and screen viewing time. Child's feeding pattern during the night will also be assessed (if the child fed or did not feed). Proportions will be used to compare responses between the intervention and control groups. Absolute values will also be compared for some questions. A scale will not be used.

    Time frame: 3 months old

  2. Screen time / sleep time questionnaire - second assessment

    This will describe total duration of sleep time and screen viewing time. Child's feeding pattern during the night will also be assessed (if the child fed or did not feed). Proportions will be used to compare responses between the intervention and control groups. Absolute values will also be compared for some questions. A scale will not be used.

    Time frame: 6 months old

  3. Screen time / sleep time questionnaire - third assessment

    This will describe total duration of sleep time and screen viewing time. Child's feeding pattern during the night will also be assessed (if the child fed or did not feed). Proportions will be used to compare responses between the intervention and control groups. Absolute values will also be compared for some questions. A scale will not be used.

    Time frame: 12 months old

  4. Breastmilk intake in child

    To determine the amount of breastmilk consumed. The mother will consume a carefully weighed dose of deuterium. Saliva samples will be collected from the mother and her infant at baseline and at 2 timepoints between 1 and 14 days following dose consumption. Deuterium enrichment will be measured by Fourier transform infrared (FTIR) Spectrometry.

    Time frame: 3 months old

  5. Mother's fat mass and lean mass (body composition) determined using deuterium (2H) dilution technique - first assessment

    Fat mass and lean mass (body composition)determined using deuterium (2H) dilution technique

    Time frame: 30-32 weeks gestation

  6. Mother's fat mass and lean mass (body composition) determined using skin fold measurements - first assessment

    Fat mass and lean mass (body composition) measured using skin fold callipers

    Time frame: 30-32 weeks gestation

  7. Mother's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - first assessment

    Fat mass and lean mass (body composition) measured using BIA analyzer

    Time frame: 30-32 weeks gestation

  8. Mother's weight - first assessment

    Mother's weight measured using a digital scale

    Time frame: 30-32 weeks gestation

  9. Mother's height

    Mother's height measured using a stadiometer

    Time frame: 30-32 weeks gestation

  10. Mother's mid-upper arm circumference - first assessment

    Mother's mid-upper arm circumference measured using a tape measure

    Time frame: 30-32 weeks gestation

  11. Mother's fat mass and lean mass (body composition) determined using skin fold measurements - second assessment

    Mother's fat mass and lean mass (body composition) determined using skin fold calliper

    Time frame: 3 months post natally

  12. Mother's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - second assessment

    Fat mass and lean mass (body composition) determined measured using BIA analyzer

    Time frame: 3 months post natally

  13. Mother's fat mass and lean mass (body composition) using deuterium dilution - second assessment

    Fat mass and lean mass (body composition) determined using deuterium dilution during breastmilk assessment

    Time frame: 3 months post natally

  14. mother's weight - second assessment

    mothers weight measured using a scale

    Time frame: 3 months post natally

  15. mother's mid-upper arm circumference - second assessment

    mother's mid-upper arm circumference measured using a tape measure

    Time frame: 3 months post natally

  16. Mother's fat mass and lean mass (body composition) determined using skin fold measurements - third assessment

    Mother's fat mass and lean mass (body composition) determined using skin fold callipers

    Time frame: 12 months post natally

  17. Mother's fat mss and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - third assessment

    mother's fat mass and lean mass (body composition) determined using BIA analyzer

    Time frame: 12 months post natally

  18. mother's weight - third assessment

    mothers weight measured using a scale

    Time frame: 12 months post natally

  19. mother's mid-upper arm circumference - third assessment

    mother's mid-upper arm circumference measured using a tape measure

    Time frame: 12 months post natally

07

Study locations

1 of 1 sites recruiting
  • Tropical Metabolism Research Unit, TMRU University of the West Indies,
    Mona, Jamaica
    Recruiting
    • Carolyn R TaylorBryan, PhD · Contactcarolyn.taylorbryan@uwimona.edu.jm · 876.927.1884
    • Asha V Badaloo, PhD · Contactasha.badaloo@uwimona.edu.jm · 876.927.1884
    • Sherine D Whyte, MSc · Sub investigator
    • Novie d YoungerColeman, PhD · Sub investigator
    • Sharmaine E Edwards, M.Sc · Sub investigator
    • Orgen L Brown, PHN · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04047888
Lead sponsor
The University of The West Indies
Collaborators
International Atomic Energy Agency
Responsible party
Sponsor
First posted
Aug 7, 2019
Start date
Jan 28, 2019
Primary completion
Dec 31, 2021 (estimated)
Completion
Dec 31, 2021 (estimated)
Last update
Aug 7, 2019

Study contacts

Carolyn R Taylor Bryan, PhD
Contact
carolyn.taylorbryan@uwimona.edu.jm
876.553.7882
Asha V Badaloo, PhD
Contact
asha.badaloo@uwimona.edu.jm
876.927.1884
Carolyn R Taylor Bryan, PhD
principal investigator · University of the West Indies, Mona

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion